Companies / Aurinia Pharmaceuticals Inc. / Activity
Activity — Aurinia Pharmaceuticals Inc.
42 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Tang Kevin CEO | Buy | Common Shares | $5.25M | +344K +2.75% | 12,838,002 9.65% of shares | high |
| Feb 27, 2026 | Tang Kevin CEO | Buy | Common Shares | $4.17M | +300K +2.65% | 11,629,500 8.74% of shares | high |
| May 29, 2026 | Tang Kevin CEO | Buy | Common Shares | $4.02M | +263K +2.15% | 12,494,481 9.39% of shares | high |
| Jun 2, 2026 | Tang Kevin CEO | Buy | Common Shares | $3.15M | +206K +1.60% | 13,044,106 9.80% of shares | high |
| Feb 27, 2026 | Tang Kevin CEO | Buy | Common Shares | $3.03M | +215K +1.85% | 11,844,339 8.90% of shares | high |
| Mar 3, 2026 | Tang Kevin CEO | Buy | Common Shares | $2.62M | +184K +1.53% | 12,229,500 9.19% of shares | high |
| Jan 2, 2026 | Greenleaf Peter CEO | Other | Common Stock | $1.81M | -113K -5.78% | 1,845,037 1.39% of shares | low |
| Mar 2, 2026 | Tang Kevin CEO | Buy | Common Shares | $1.65M | +116K +0.97% | 12,045,292 9.05% of shares | high |
| Feb 20, 2026 | Greenleaf Peter CEO | Other | Common Stock | $1.44M | -100K -5.43% | 1,744,866 1.31% of shares | low |
| Mar 2, 2026 | Greenleaf Peter CEO | Other | Common Stock | $1.43M | -101K -5.20% | 1,840,379 1.38% of shares | low |
| Mar 2, 2026 | Tang Kevin CEO | Buy | Common Shares | $1.20M | +84K +0.71% | 11,929,500 8.97% of shares | high |
| Jan 2, 2026 | Donley Matthew Maxwell Executive | Other | Common Stock | $682.5K | -43K -5.79% | 695,801 0.52% of shares | low |
| Jan 2, 2026 | Robertson Stephen P. Executive | Other | Common Stock | $644.1K | -40K -7.23% | 517,934 0.39% of shares | low |
| Jan 2, 2026 | Miller Joseph M Executive | Other | Common Stock | $640.6K | -40K -6.38% | 589,127 0.44% of shares | low |
| Mar 2, 2026 | Donley Matthew Maxwell Executive | Other | Common Stock | $579.2K | -41K -5.65% | 680,299 0.51% of shares | low |
| Mar 2, 2026 | Miller Joseph M Executive | Other | Common Stock | $533.0K | -38K -6.11% | 576,421 0.43% of shares | low |
| Mar 2, 2026 | Robertson Stephen P. Executive | Other | Common Stock | $519.0K | -37K -6.73% | 505,861 0.38% of shares | low |
| Feb 20, 2026 | Robertson Stephen P. Executive | Other | Common Stock | $498.8K | -35K -6.69% | 483,296 0.36% of shares | low |
| Feb 20, 2026 | Donley Matthew Maxwell Executive | Other | Common Stock | $473.8K | -33K -4.73% | 662,900 0.50% of shares | low |
| Feb 20, 2026 | Miller Joseph M Executive | Other | Common Stock | $466.9K | -32K -5.50% | 556,703 0.42% of shares | low |
| Feb 2, 2026 | Keenan Greg Executive | Other | Common Stock | $167.9K | -12K -8.65% | 121,932 0.09% of shares | low |
| Mar 6, 2026 | Keenan Greg Executive | Other | Common Stock | $115.5K | -8K -4.96% | 154,449 0.12% of shares | low |
| May 29, 2026 | Tang Kevin CEO | Buy | Common Shares | $35.3K | +2K +0.02% | 12,231,799 9.19% of shares | low |
| Feb 27, 2026 | Tang Kevin CEO | Buy | Common Shares | $23.0K | +2K +0.01% | 11,845,939 8.90% of shares | low |
| Jun 1, 2026 | Tang Kevin CEO | Buy | Common Shares | $1.5K | +99 +<0.01% | 12,838,101 9.65% of shares | low |
| Feb 27, 2026 | Robertson Stephen P. Executive | Grant | Common Stock | $0 | +59K +12.23% | 542,386 0.41% of shares | low |
| Jan 2, 2026 | Robertson Stephen P. Executive | Grant | Common Stock | $0 | +49K +9.54% | 557,434 0.42% of shares | low |
| Feb 27, 2026 | Miller Joseph M Executive | Grant | Common Stock | $0 | +57K +10.28% | 613,932 0.46% of shares | low |
| Jan 2, 2026 | Miller Joseph M Executive | Grant | Common Stock | $0 | +49K +8.49% | 626,399 0.47% of shares | low |
| Feb 27, 2026 | Donley Matthew Maxwell Executive | Grant | Common Stock | $0 | +58K +8.77% | 721,060 0.54% of shares | low |
| Jan 2, 2026 | Donley Matthew Maxwell Executive | Grant | Common Stock | $0 | +54K +7.96% | 734,631 0.55% of shares | low |
| Feb 27, 2026 | Greenleaf Peter CEO | Grant | Common Stock | $0 | +196K +11.26% | 1,941,269 1.46% of shares | low |
| Feb 27, 2026 | Keenan Greg Executive | Grant | Common Stock | $0 | +41K +33.29% | 162,518 0.12% of shares | low |
| Jan 2, 2026 | Greenleaf Peter CEO | Grant | Common Stock | $0 | +165K +9.24% | 1,954,329 1.47% of shares | low |
| Jun 4, 2026 | Johnson Craig A Director | Grant | Director Stock Option (right to buy) | — | +24K | 23,931 0.02% of shares | low |
| Jun 4, 2026 | Nova Tina Susan Director | Grant | Director Stock Option (right to buy) | — | +24K | 23,931 0.02% of shares | low |
| Jun 2, 2026 | Tang Kevin CEO | Other | Short Put Options (potential obligation to buy) | — | +10K | 10,000 <0.01% of shares | low |
| Feb 27, 2026 | Robertson Stephen P. Executive | Grant | Employee Stock Option (right to buy) | — | +99K | 98,813 0.07% of shares | low |
| Feb 27, 2026 | Miller Joseph M Executive | Grant | Employee Stock Option (right to buy) | — | +96K | 95,700 0.07% of shares | low |
| Feb 27, 2026 | Donley Matthew Maxwell Executive | Grant | Employee Stock Option (right to buy) | — | +97K | 97,256 0.07% of shares | low |
| Feb 27, 2026 | Greenleaf Peter CEO | Grant | Employee Stock Option (right to buy) | — | +328K | 328,424 0.25% of shares | low |
| Feb 27, 2026 | Keenan Greg Executive | Grant | Employee Stock Option (right to buy) | — | +68K | 67,870 0.05% of shares | low |